SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-19-009884
Filing Date
2019-01-15
Accepted
2019-01-15 17:18:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRER14A d678811dprer14a.htm PRER14A 1595644
2 GRAPHIC g678811apc1.jpg GRAPHIC 221034
3 GRAPHIC g678811apc2.jpg GRAPHIC 196789
4 GRAPHIC g678811bpc1.jpg GRAPHIC 171666
5 GRAPHIC g678811bpc2.jpg GRAPHIC 175234
6 GRAPHIC g678811g30c53.jpg GRAPHIC 45469
  Complete submission text file 0001193125-19-009884.txt   2712947
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-35405 | Film No.: 19527679
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences